Why basic research is the venture capital of the biomedical world

In this recently posted video on the Stanford Medicine YouTube channel, scientists discuss the vital role basic science plays in breakthroughs in medicine and how research of the past has opened numerous new lines of inquiry. Included in the video are comments from Stanford emeritus professor Paul Berg, PhD, whose work with recombinant DNA earned him the Nobel Prize in Chemistry in 1980. Berg discusses his prize-winning research and how it, along with other efforts at Stanford, contributed to the creation of the biotechnology revolution.

Berg’s research underscores the importance of continued investments in basic science research. He says, “If funding becomes so critical then young people won’t even come into the field.” His sentiments are echoed by colleagues in the video who warn that without continued investment in basic research, the United States will fall behind and may possibly never regain its position as a global leader in science and medicine.

Previously: Future of medical research is at risk, says Stanford medical school dean, The economic benefits of publicly funded medical research, Report: NIH investments created $68 billion in economic activity last year and Academic medical centers bring billions to the economy